General Information of This Drug (ID: DM9AJRB)

Drug Name
Zinc Sulfate   DM9AJRB
Synonyms
Zinc sulfate; Zinc sulphate; 7733-02-0; Zincate; White vitriol; Zinc sulfate (1:1); Complexonat; Zinklet; Orazinc; Bonazen; Zinkosite; Zincomed; Solvezinc; Solvezink; Optraex; Optised; Medizinc; Neozin; ZnSO4; Zinc sulfate anhydrous; White copperas; Zinc vitriol; Zinci Sulfas; Visine-ac; Prefrin-Z; Zincum Sulfuricum; Zink-Gro; OP-Thal-zin; Bufopto zinc sulfate; Sulfuric acid, zinc salt (1:1); Zinc vitriol (VAN); component of Phenylzin; Caswell No. 927; Zinc Sulfate [USP]; White vitriol (VAN); Zinc sulfate (ZnSO4); Zinc-200; NU-Z
Indication
Disease Entry ICD 11 Status REF
Zinc deficiency 5B5K.2 Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Zinc Sulfate + Fluconazole DCV5GP2 Fluconazole Stem Cell Transplant Complications [2]
Doxycycline + Zinc Sulfate DC8NTS1 Doxycycline COVID-19 [3]
Zinc Sulfate + Azithromycin DCDHS4Z Azithromycin COVID-19 [3]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 ClinicalTrials.gov (NCT03159845) Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies
3 ClinicalTrials.gov (NCT04370782) Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting